Management of uterine sarcomas and prognostic indicators: real world data from a single-institution
Article 2018 en
Authors
AK
Anastasios Kyriazoglou
ML
Michalis Liontos
DZ
Dimitrios C. Ziogas
Abstract
1 min read
Mitotic count appears to be independent prognostic factor while further insights are needed to improve adjuvant and palliative treatment of uterine sarcomas.
Isabelle Ray‐Coquard, Paolo G. Casali, Sabrina Croce, Fiona M. Fennessy, D. Fischerová, Robin L. Jones, Roberta Sanfilippo, Ignacio Zapardiel, Frédéric Amant, Jean Yves Blay, Javier Martín‐Broto, Antonio Casado, Sarah Chiang, Angelo Paolo Dei Tos, Rick L. M. Haas, Martee L. Hensley, Peter Hohenberger, Jae‐Weon Kim, Se Ik Kim, Mehmet Mutlu Meydanlı, Patricia Pautier, Albiruni R. Abdul Razak, Jalid Sehouli, Winan J. van Houdt,
Samuel Hidalgo-Ríos, Jaime Carrillo, David S. Moura, Silvia Stacchiotti, Antonio López–Pousa, Andrés Redondo, Antoîne Italiano, Antonio Gutiérrez, Giovanni Grignani, Nadia Hindi, José Antonio López‐Guerrero, Xavier García del Muro, Javier Martínez‐Trufero, Emanuela Palmerini, Ana García, Daniel Bernabéu, Axel Le Cesne, Paolo G. Casali, Jean Yves Blay, Josefina Cruz Jurado,
Discussion(0)
No comments yet. Be the first to comment.